US Marijuana Rescheduling Highly Likely by End of 2025

The possibility of marijuana being rescheduled by the U.S. Drug Enforcement Administration (DEA) has gained significant momentum, with current indicators suggesting a high likelihood of such a change occurring by the end of 2025. This potential shift could fundamentally alter the legal status of cannabis at the federal level.

The process involves a review by the DEA, which assesses substances based on their potential for abuse and accepted medical use. Recent discussions and actions by governmental bodies have signaled a re-evaluation of marijuana's classification, which currently places it as a Schedule I controlled substance – the most restrictive category, alongside drugs like heroin. A rescheduling would likely move marijuana to a less restrictive category, potentially impacting research, state-level regulations, and the burgeoning cannabis industry.

While the final decision rests with the DEA, the strong indications and the ongoing review process contribute to a prevailing sentiment that a rescheduling event is probable within the specified timeframe. This development is being closely watched by policymakers, industry stakeholders, and the public alike, as it represents a significant potential change in U.S. drug policy.